Navigation Links
Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society
Date:10/1/2008

Data support the therapeutic potential of Amylin's integrated neurohormonal

approach to obesity pharmacotherapy

SAN DIEGO, Oct. 1 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today announced that new data for its pipeline obesity candidates will be presented at the 2008 Annual Scientific Meeting of The Obesity Society in Phoenix October 3-7. The Obesity Society's annual meeting is one of the largest and most comprehensive scientific conferences in the field of obesity.

Amylin will present scientific data through 11 oral and poster presentations, showcasing progress in the company's obesity pipeline. In addition to Amylin's lead clinical-stage programs in obesity, pramlintide/metreleptin and AC2307, new findings will also be presented on various preclinical programs, including a new Y-family mimetic and Amylin's peptide hybrid (phybrid) platform. Additional information will be presented during two corporate-sponsored symposia focused on the emerging peptide hormone approach to the treatment of obesity and the new science and therapeutic research that shows promise to reduce the risk of cardiovascular disease associated with obesity and type 2 diabetes.

"We are excited to present our latest work on the obesity front at this year's Obesity Society meeting, and will be sharing compelling data that demonstrates how our programs have the potential to provide significant weight loss that can be sustained over time," said Daniel Bradbury, president and chief executive officer at Amylin Pharmaceuticals, Inc. "Our unique neurohormonal approach to obesity, and our deep expertise in peptide hormones, enables us to develop drugs that may help regulate how many calories we eat, burn and st
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
2. Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings
3. Critical Pharmaceuticals Enter Sustained Release hGH Arena
4. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
5. Potentia Pharmaceuticals Announces Positive Safety Data and Study Expansion in Phase I Trial for Lead Drug Candidate POT-4
6. Quark Pharmaceuticals Announces First RNAi Drug Candidate Having a Novel, Proprietary Structure Covered by Quark Intellectual Property
7. Lotus Pharmaceuticals, Inc.s New Drug Laevo-Bambutero Begins Evaluation for Clinical Trials
8. VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial
9. QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy
10. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
11. Oramed Pharmaceuticals Commences Phase 2A Trials of its Oral Insulin Capsule on Type 1 Diabetics

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...re/--Reportlinker.comannouncesthatanewmarketresear...alDrugDelivery-USMarketTrends&Analysis http:/...ivery---US-Market-Trends--Analysis.html ,, The...ionoftherapeuticapplicationsfromthedeliveryofconve...ctherapeuticdrugs.Thefutureofthetechnologyhingeson...
(Date:11/25/2009)....25/PRNewswire/-- ChemoCentryx,Inc.,announcedtoda...T-1(theProspectiveRandomizedOralTherapyEvaluationi...patientswithmoderate-to-severeCrohn,sdiseasedemons...abilityprofile.Thestudydemonstratedevidenceofclini...dasa70-pointdecreaseintheCrohn,sDiseaseActivityInd...
(Date:11/24/2009)...Newswire-FirstCall/--Endologix,Inc.(Nasdaq: ELGX )...sorders,announcedtodaythatithasfiledamotiontostay,...tlawsuitbroughtagainstitinOctober2009byCook,Inc.Th...ianapolis,Indiana. ,, Endologixhasrequestedthat...TrademarkOffice(USPTO)conductsproceedingstore-exam...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2First Annual Conference of National Association of Healthcare Advocacy Consultants 28NAHAC 29 to Be Held Nov 14 15 3B Board of Directors Announced 59341 1First Annual Conference of National Association of Healthcare Advocacy Consultants 28NAHAC 29 to Be Held Nov 14 15 3B Board of Directors Announced 59341 2The Governator and the Disintegrator 3A A Sharp Match Holding Pharmaceutical Companies Accountable 5416 1The Governator and the Disintegrator 3A A Sharp Match Holding Pharmaceutical Companies Accountable 5416 2The Governator and the Disintegrator 3A A Sharp Match Holding Pharmaceutical Companies Accountable 5416 3Vivacare Delivers Medication Information to Patients through Doctor Websites 59336 1Vivacare Delivers Medication Information to Patients through Doctor Websites 59336 2Vivacare Delivers Medication Information to Patients through Doctor Websites 59336 3
...re-FirstCall/ -- Amylin,Pharmaceuticals, Inc. toda...tes drugs, BYETTA(R) (exenatide) injection and,SYM...peline,candidates will be presented at the America...fic Sessions being held in Chicago, IL,from June 2...esentation during the meeting that will be availab...
...20, 2007 - Neoprobe Corporation,(OTCBB:NEOP), a di...diovascular surgical and diagnostic products, toda...lticenter Phase 2 clinical,study of its lead clini...A-mannosyl-dextran). Lymphoseek is a proprietary,r... with handheld,gamma detection devices, such as Ne...
Other Medicine Technology:Amylin Pharmaceuticals to Present New Data from Broad Diabetes and,Obesity Programs at ADA 2007 2Amylin Pharmaceuticals to Present New Data from Broad Diabetes and,Obesity Programs at ADA 2007 3Amylin Pharmaceuticals to Present New Data from Broad Diabetes and,Obesity Programs at ADA 2007 4Neoprobe Phase 2 Lymphoseek Trial Meets Primary Endpoint 2Neoprobe Phase 2 Lymphoseek Trial Meets Primary Endpoint 3
(Date:11/26/2009)...ge that,s too big or too heavy can lead to strains...ay News) -- There may be nothing wrong with stuffi... want to do the same thing with your suitcase as y...eople were treated in 2008 in U.S. hospital emerge...ical facilities for luggage-related injuries, such...
(Date:11/26/2009)... Dr. David Kim of the Live Lif...urgery in Dallas , is one of a growing number of p...ial networking sites to connect with individuals w...t to fight morbid obesity. Dr. Kim is utilizing Fa...ation about his practice with the community. , ...
(Date:11/26/2009)... Ennis & Ennis, P.A. is of...for users of Yaz and Yasmin birth control pills wh...onary Embolism, Stroke, Heart Attack or other rela...d. Women can call toll free at 1-800-856-6405 or g...law.com and fill out an online case evaluation fo...
(Date:11/25/2009)..., EMERYVILLE,Calif.,Nov.25/PRNewswire-FirstCall/-...ouncedthatthecompanywillhosttwoinvestoreventsinDec...9-9:00a.m.CT/10:00a.m.ET ,, Principalinvestig...zomibinrelapsedand/orrefractorymultiplemyeloma,asf...nualMeetingandExpositioninNewOrleans,LA.Thetelecon...
(Date:11/25/2009)..., LONGBEACH,Calif.,Nov.25/PRNewswire/--Thanksgivi...dseniorsinthegreaterLongBeachareathankstoFaithInAc...ependenceatHome(IAH),adivisionofSCANHealthPlan.For...edsofvolunteerstodeliverwarmThanksgivingmealstosen...,SouthLosAngelesandsurroundingcities. ,, "Ourwa...
Breaking Medicine News(10 mins):Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2
...eb. 10 Valentine,s Day often includes expensive d...llet and waistline. , , But results of a recent A...ould be better off scheduling romantic -- and hear...hile on a walk and 93 percent of adults believe th...
...RRISBURG, Pa., Feb. 10 Samples taken from the 39 ...season have all tested negative for chronic wastin...he Pennsylvania Game Commission,s wildlife veterin...WD testing for the 4,247 hunter-killed deer sample...
... , NCCN names Cold Spring Publishing, LLC, as the... the National Comprehensive Cancer Network. Cold S...ing company led by Jack Gentile, founder of PRR, I...logy(TM). , , FORT WASHINGTON, Pa., Feb. 10 JNC...
...ealthcare Training and Marketing Consultant brings...lients design and deliver more effective education... Creative marketing and communications agency Broa...t after years as a leading industry consultant. As...
... Feb. 10 HMS (Nasdaq: HMSY ) today announced th...from Neighborhood Health Providers and Optima Heal...aid lives to its managed care portfolio. HMS will ...ce coverage not previously known for its Medicaid ...
..., IL, Feb. 10, 2009 A prestigious panel of pain-m...ociety (APS) www.ampainsoc.org and the American ...first comprehensive clinical practice guideline to... current issue of The Journal of Pain , www.jpai...
Other Medicine News:Health News:American Heart Association Survey: Romance and Walking a Perfect Match 2Health News:Hunter-Killed Elk Test Negative for CWD and Other Diseases 2Health News:Hunter-Killed Elk Test Negative for CWD and Other Diseases 3Health News:Hunter-Killed Elk Test Negative for CWD and Other Diseases 4Health News:Hunter-Killed Elk Test Negative for CWD and Other Diseases 5Health News:JNCCN Names New Publishing Company 2Health News:JNCCN Names New Publishing Company 3Health News:Broadstreet Names Dorian Fabio Executive Vice President of Learning and Performance Improvement 2Health News:HMS Awarded New Contracts for Managed Care Services 2Health News:New guidelines for prescribing opioid pain drugs published 2Health News:New guidelines for prescribing opioid pain drugs published 3Health News:New guidelines for prescribing opioid pain drugs published 4
...ested Timeter® Classic Flowmeters demonstrates...oviders and patients alike. You can see it in the ... can see it in the performance, year after year. E...d and engineered to the highest standards of perfo...
Soft-Touch Timeter® 15 LPM Dual Oxygen Flowmeter w/Y Bar & 2 Power Take Off
Soft-Touch Timeter® 15 LPM Dual Oxygen Flowmeter w/T Bar
Soft-Touch Timeter® 8 LPM Flowmeter
Medicine Products: